P. Pfeffer

发表

Infections in cyclosporine-treated kidney graft recipients: beneficial effect of cotrimoxazole prophylaxis.

P. Fauchald, K. Berg, I. Brekke, 1990, Transplantation Proceedings.

Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.

K. Rootwelt, K. Erichsen, J. Fjeld, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Minimally invasive renal auto-transplantation: the first report.

O. Øyen, P. Line, P. Pfeffer, 2010, The Journal of surgical research.

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics.

L. P. Van den Heuvel, T. V. van Kuppevelt, H. Bangstad, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation

A. Hartmann, K. Godang, J. Bollerslev, 2009, Scandinavian journal of clinical and laboratory investigation.

Calcineurin Inhibitor‐Free Immunosuppression in Renal Allograft Recipients with Thrombotic Microangiopathy/Hemolytic Uremic Syndrome

A. Hartmann, S. Bergan, K. Midtvedt, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Determinants of bone mass in end‐stage renal failure patients at the time of kidney transplantation

A. Hartmann, K. Godang, J. Bollerslev, 2008, Clinical transplantation.

Determinants of short-term changes in body composition following renal transplantation

A. Hartmann, T. Jenssen, J. Bollerslev, 2009, Scandinavian journal of urology and nephrology.

HLA‐RESTRICTED CYTOTOXICITY AGAINST MALE‐SPECIFIC (H‐Y) ANTIGEN AFTER ACUTE REJECTION OF AN HLA‐IDENTICAL SIBLING KIDNEY CLONAL DISTRIBUTION OF THE CYTOTOXIC CELLS

E. Thorsby, P. Pfeffer, 1982, Transplantation.

Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigens.

P. Fauchald, H. Lindberg, K. Berg, 1987, Transplantation proceedings.

HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated.

E. Thorsby, S. Simonsen, A. Foerster, 1988, Transplantation proceedings.

P. Fauchald, T. Leivestad, O. Søreide, 1998, Transplantation.

P. Fauchald, T. Leivestad, O. Søreide, 1998 .

Minimally invasive living donor nephrectomy – introduction of hand‐assistance

H. Holdaas, G. Mjøen, O. Øyen, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Experience with cyclosporine in 1519 kidney transplantations from living donors in a national transplant programme, 1983-2002.

E. Thorsby, P. Fauchald, T. Leivestad, 2004, Transplantation proceedings.

Laparoscopic and open surgery for pheochromocytoma

E. Fosse, T. Mala, B. Edwin, 2001, BMC surgery.

Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study

H. Holdaas, L. Mjörnstedt, K. Midtvedt, 2008, Clinical transplantation.

Declining Intracellular T-Lymphocyte Concentration of Cyclosporine A Precedes Acute Rejection in Kidney Transplant Recipients

A. Åsberg, A. Hartmann, S. Bremer, 2008, Transplantation.

Influence of Renal Angiography in Living Potential Kidney Donors

P. Fauchald, T. Scholz, P. Pfeffer, 1991, Acta radiologica.

Fibro-muscular renal artery disease treated by extracorporeal vascular reconstruction and renal autotransplantation: short- and long-term results.

I. Brekke, O. Bentdal, G. Sødal, 1992, European journal of vascular surgery.

Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?

P. Fauchald, T. Leivestad, B. Møller, 1999, Transplantation proceedings.

Long-term risks for kidney donors.

F. Dekker, I. Holme, A. Hartmann, 2014, Kidney international.

Human heart transplantation. Rejection risk factors.

E. Thorsby, H. Lindberg, M. Abdelnoor, 1988, APMIS. Supplementum.

Complicated Renal Calculous Disease Treated by Extracorporeal Surgery and Autotransplantation

G. Sødal, P. Pfeffer, H. Bondevik, 1997 .

Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients

C. Dudley, G. Tydén, J. Pattison, 2003, Transplantation.

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

P Jensen, S Hansen, B Møller, 1999, Journal of the American Academy of Dermatology.

Improvement of post-transplant lymphocele treatment in the laparoscopic era

Vikas Siwach, Bjørn Edwin, B. Edwin, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Laparoscopic management of posttransplant pelvic lymphoceles.

A. Bakka, A. Foss, P. Jørgensen, 1995, Transplantation proceedings.

Improvement of post‐transplant lymphocele treatment in the laparoscopic era

B. Edwin, A. Foss, O. Øyen, 2002 .

Laparoscopic adrenalectomy: Norwegian single-center experience of 242 procedures.

B. Edwin, B. Røsok, A. Kazaryan, 2009, Journal of laparoendoscopic & advanced surgical techniques. Part A.

LAPAROSCOPIC VS OPEN LIVING DONOR NEPHRECTOMY EXPERIENCES FROM A PROSPECTIVE, RANDOMISED, SINGLE CENTER STUDY; FOCUSING ON DONOR SAFETY

B. Edwin, M. Andersen, O. Øyen, 2004, Transplantation.

Laparoscopic living donor nephrectomy: introduction of simple hand-assisted technique (without handport).

B. Edwin, A. Foss, O. Øyen, 2003, Transplantation proceedings.

Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.

E. Thorsby, T. Leivestad, P. Pfeffer, 2004, Transplantation Proceedings.

EFFECTS OF METHYLPREDNISOLONE ON THE IN VITRO GENERATION OF HUMAN SECONDARY CYTOTOXIC LYMPHOCYTES

H. Hirschberg, B. Randazzo, P. Pfeffer, 1980, Transplantation.

Genomic HLA-DRB1 matching further improves clinical course after renal transplantation.

E. Thorsby, P. Fauchald, T. Leivestad, 1995, Transplantation Proceedings.

Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.

E. Thorsby, P. Fauchald, T. Leivestad, 1993, Transplantation Proceedings.

Does genomic HLA-DR matching further enhance the effects of serologic DR matching in clinical renal transplantation?

E. Thorsby, P. Fauchald, T. Leivestad, 1994, Transplantation Proceedings.

Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation.

E. Thorsby, A. Foerster, T. Frøysaker, 1987, Transplantation proceedings.

Minimally invasive kidney transplantation: the first experience.

A. Hartmann, O. Øyen, T. Scholz, 2006, Transplantation proceedings.

Histocompatibility typing by cell mediated lympholysis (CML): workshop II technical standardization.

H. Johnsen, D. Charmot, R. Wank, 2008, Tissue antigens.

[Cancer in organ transplanted patients].

P. Pfeffer, 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

C2 monitoring in maintenance renal transplant recipients: is it worthwhile?

P. Fauchald, S. Hallan, E. Svarstad, 2003, Transplantation.

Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion

S. Chadban, F. Schena, E. Thervet, 2003, Transplantation.

Aortoiliac reconstruction in preparation for renal transplantation

P. Fauchald, I. Brekke, G. Sødal, 1993, Transplant international : official journal of the European Society for Organ Transplantation.

Gender imbalance among donors in living kidney transplantation: the Norwegian experience.

P. Fauchald, T. Leivestad, I. Os, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal transplantation and intestinal urinary diversion: a 10-year experience.

I. Brekke, O. Bentdal, G. Sødal, 1993, Transplantation proceedings.

Anamnestic cancer: how long should the cancer-free interval be before renal transplantation?

P. Fauchald, T. Leivestad, I. Brekke, 1997, Transplantation proceedings.

Experimental cardiac transplantation and chronic Chagas' disease in dogs.

P. Fauchald, T. Leivestad, D. Albrechtsen, 1988 .

Renal replacement therapy in patients over 60 years of age.

P. Fauchald, T. Leivestad, D. Albrechtsen, 1988, Transplantation proceedings.

A 1‐Year Randomized, Double‐Blind, Placebo‐Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation

Inge Christoffer Olsen, A. Åsberg, A. Hartmann, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?

P. Gjersvik, P. Fauchald, T. Leivestad, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

CELL‐MEDIATED CYTOTOXICITY TOWARD THE DONOR IN PATIENTS WITH WELL‐FUNCTIONING KIDNEY GRAFTS: POSSIBLE MECHANISM OF SPECIFICALLY REDUCED CYTOTOXIC RESPONSE

E. Thorsby, H. Hirschberg, P. Pfeffer, 1983, Transplantation.

The Norwegian Model Full Utilisation of Both Living and Deceased Donors to Meet the Need for Organs

P. Pfeffer, 2016 .

Scandiatransplant report 2009.

S. Sørensen, M. Olausson, N. Grunnet, 2010, Transplantation proceedings.

Analysis of infiltrating lymphocytes from fine needle aspiration biopsies in kidney transplant patients by a rapid and sensitive immunomagnetic method.

E. Thorsby, G. Gaudernack, H. Gjertsen, 1989, Transplantation proceedings.

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

S Hansen, B Møller, P Jensen, 1999, Journal of the American Academy of Dermatology.

HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.

E. Thorsby, G. Sødal, P. Pfeffer, 1981, Scandinavian journal of urology and nephrology. Supplementum.

DONOR‐SPECIFIC DECREASED CELL‐MEDIATED CYTOTOXICITY IN RECIPIENTS OF WELL FUNCTIONING, ONE HLA HAPLOTYPE‐MISMATCHED KIDNEY ALLOGRAFTS

E. Thorsby, H. Hirschberg, P. Pfeffer, 1983, Transplantation.